scholarly journals sLORETA neurofeedback in fibromyalgia

2020 ◽  
Vol 3 (1) ◽  
pp. 1-10
Author(s):  
Ruben Pérez-Elvira ◽  
Ana Jiménez Gómez

Fibromyalgia is a chronic and incapacitating condition that produces, as main symptoms, pain, and stiffness. In addition to these physical symptoms, it is also accompanied by psychological symptoms such as cognitive deficits, anxiety, and depression. One of the non-pharmacological treatments that have been used in this pathology in recent years is neurofeedback. In this study, we analyze the efficacy of sLORETA Neurofeedback in the case of fibromyalgia. The experimental subject was a 37-year-old patient. Quantified electroencephalography studies were applied on three occasions, one initial, another after fifteen days of waiting list, and another after treatment. Psychometric scales were also applied at the same time to evaluate the patient's psychological and physical state. The treatment consisted of 5 sessions of Neurofeedback LORETA in Brodmann area 2. After the treatment, a neurometric, psychometric, and clinical improvement were found. The improvement of the patient after 5 sessions is relevant since previous studies using neurofeedback in fibromyalgia, despite finding positive results, needed a higher number of sessions to achieve relevant results. Therefore, the intervention with neurofeedback LORETA in fibromyalgia patients could be an alternative or complement to current treatments.

Author(s):  
Marvin Omar Delgado Guay

Most advanced cancer patients develop psychological symptoms, either alone or in combination with physical symptoms. Frequently psychological symptoms complicate management of physical symptoms such as pain. Routine screening is essential for diagnosis. Among the many possible psychological symptoms, the most common are adjustment disorders, anxiety disorders, depressive disorders, and cognitive disorders, which can be major sources of distress for patients and can pose significant management problems. Treatment may include combination of psychotherapy as well as pharmacotherapy. In this chapter we will review the diagnosis, and management of the most common psychological symptoms such as anxiety and depression experienced by the patients receiving palliative care.


2019 ◽  
Vol 15 (4) ◽  
pp. 808-822 ◽  
Author(s):  
Alessandro Lo Presti ◽  
Paolo Pappone ◽  
Alfonso Landolfi

Workplace bullying is a critical issue for its negative consequences on victims’ health and well-being. This study aimed at examining the intermediate roles of anxiety and depression, in the relations between workplace bullying as a predictor, and physical and psychological negative symptoms as outcomes. In particular, it was hypothesized that workplace bullying would be associated with higher anxiety and depression and, through them, with higher physical and psychological negative symptoms. We sampled 151 Italian employees, who called on a workplace bullying public clinical center as victims and filled a paper-and-pencil questionnaire. Results of bootstrapped regressions showed that only anxiety mediated the association of workplace bullying with negative physical symptoms while both anxiety and depression mediated its association with negative psychological symptoms. The results have implications for the development of appropriate intervention strategies for both prevention and clinical treatment. In particular, timely diagnosing and treating anxiety and depression could prevent subsequent problems related to psychological and physical symptoms such as colitis, headache, tiredness, nervousness, etc. Organizational interventions in terms of primary prevention are also discussed. From an empirical standpoint, the study contributed to disentangling the differential roles of anxiety and depression with respect to physical and psychological symptoms; moreover, overcoming a common limit of workplace bullying research, the current study was carried out on actual victims.


2016 ◽  
Vol 9 (2) ◽  
pp. 175-182 ◽  
Author(s):  
Rebecca Dawber ◽  
Kathy Armour ◽  
Peter Ferry ◽  
Bhaskar Mukherjee ◽  
Christopher Carter ◽  
...  

ObjectivesA prospective study of symptom assessments made by a healthcare professional (HCP; named nurse) and an informal caregiver (ICG) compared with that of the patient with a terminal diagnosis. To look at the validity of HCP and ICG as proxies, which symptoms they can reliably assess, and to determine who is the better proxy between HCP and ICG.MethodsA total of 50 triads of patient (>65 years) in the terminal phase, ICG and named nurse on medical wards of an acute general hospital. Assessments were made using the patient and caregiver versions of the palliative outcome scale (POS), all taken within a 24 h period. Agreement between patient-rated, ICG-rated and HCP-rated POS and POS for symptoms (POS-S) was measured using weighted-κ statistics. Demographic and clinical data on each group of participants were collected.ResultsICG assessments have higher agreement with those of the patient than HCP. Better agreement in both groups was found for physical symptoms, and best agreement was for pain. The worst agreements were for psychological symptoms, such as anxiety and depression, and for satisfaction with information given. Psychological symptoms are overestimated by both ICG and HCP.ConclusionsICGs are more reliable proxies than HCPs. A trend for overestimation of symptoms was found in both groups which may lead to undervaluation of the quality of life by proxy and overtreatment of symptoms. This highlights the need to always use the patient report when possible, and to be aware of the potential flaws in proxy assessment. Reasons for overestimation by proxies deserve further research.


2021 ◽  
Author(s):  
David A. Booth

Some psychologists have viewed sadness and depression as reactions to past loss, while regarding fear and anxiety as responses to future threat. Such assumptions conflict with common experience of gloom about the future and worry about the past. Recent research on these issues by experiment and/or by questionnaire remains inconclusive. The psychometric questionnaires purport to be situation-free and the laboratory experiments use artificial tasks; hence, neither approach addresses realities in the present, past or future. In recent psychometrics, the distinction between anxiety and depression has been dissolved into one category of negative affect. One widely used inventory for separating the two emotions conflates depression with the absence of a good mood. These deficiencies were addressed in a diverse convenience sample (N = 379) by running an experiment entirely within a questionnaire. Each of the 40 question items was a miniature vignette, describing a past or future emotive situation while in bad or good mood. Five categories of situation varied in proportion of threat to loss. Strength and valence of affective response were measured by degree of autobiographical assent to or dissent from an item. This inventory provides fully affect-balanced situation-oriented depression / anxiety scaling.Effect sizes from analysis of variance showed that anxiety arises from past as well as future threats, while depression is at least as strongly oriented to losses in the future as in the past. Variation in category of situation or in valence of mood also had substantial effects. It is concluded that worry and gloom travel freely across time and situations, whether present mood is bad or good. Both laboratory experiments and psychometric scales come closer to actual processes of emotion and motivation when they revivify familiar situations using valence-balanced verbal stimuli.


2007 ◽  
Vol 16 (4-5) ◽  
pp. 223-231
Author(s):  
Marousa Pavlou ◽  
Rosalyn A. Davies ◽  
Adolfo M. Bronstein

Patients with chronic vestibular dysfunction often experience visually-induced aggravation of dizzy symptoms (visual vertigo; VV). The Situational Characteristics Questionnaire (SCQ), Computerized Dynamic Posturography or Rod and Frame Test (RFT) are used to assess VV symptoms. This study evaluates whether correlations exist between these three tests, their ability to identify patients with VV and whether emotional state correlates with VV symptoms. Tests were completed by 20 normal controls (Group NC), 20 patients with vestibular dysfunction plus VV (Group VV) and 13 without VV (Group NVV). Additionally, the Vertigo Symptom Scale (VSS-V) was applied to quantify general, non-visually induced vertigo (dizziness, lightheadedness and/or spinning) and imbalance. Autonomic (VSS-A) and psychological symptoms (Hospital Anxiety and Depression questionnaire; HAD) were also assessed. With the SCQ 100% of Group VV scored outside normal ranges and scores differed significantly between Group VV and both Groups NC and NVV. RFT values were not significantly different between groups; only 15% of patients scored outside normal ranges. Posturography scores were abnormal for 50% of patients; significant differences were noted between Groups NC and VV for composite scores and ratios 3/1, 4/1, 5/1 and 6/1 (indicative of abnormal sensory re-weighting). There were no correlations between the three data sets in patients. Anxiety and depression scores significantly differed between Groups NC and VV but not between patient groups; this indicates that psychological symptoms may be present in either patient group. The SCQ can be used to corroborate an initial clinical diagnosis of VV and quantify its severity in patients with vestibular dysfunction. Posturography data suggested patients with VV have a sensory re-weighting abnormality. The rod and frame test results and posturography findings agree less with the clinical diagnosis of VV. Psychological symptoms may need to be addressed.


2017 ◽  
Vol 29 (9) ◽  
pp. 1405-1407
Author(s):  
Viviana M. Wuthrich

It is well-established that as people age, deterioration in cognitive abilities including processing speed, memory, and cognitive flexibility occurs, although vast individual differences occur in the rate and consequences of this decline (Christensen, 2001). Anxiety and depression in late life are also associated with specific cognitive deficits in memory and executive functioning that may impact on new learning (Yochim et al., 2013). Therefore, it is possible that cognitive changes make it more difficult for older adults to learn how to change their thinking particularly in the context of psychological therapy.


2017 ◽  
Vol 7 (2) ◽  
pp. 16-22
Author(s):  
Ana Cláudia Miranda Santos ◽  
Maria Vilela Pinto Nakasu

Introdução: O paciente em tratamento hemodialítico pode ter um sentimento ambíguo entre o medo de viver e morrer. A condição crônica da doença renal e o tratamento hemodialítico são consideradas fontes estressoras permanentes. Além de mais vulneráveis ao estresse, vivenciam condições particulares que configuram em perdas que afetam a si e seus familiares, podendo apresentar sintomas depressivos decorrentes das mesmas. Objetivos: Investigar a prevalência de sintomas de estresse e depressão em pacientes renais crônicos sob tratamento dialítico no Hospital Escola (HE) de Itajubá, no estado de Minas Gerais, Brasil. Métodos: A pesquisa foi realizada individualmente, com 59 pacientes que realizam tratamento de diálise no HE de Itajubá. Após o esclarecimento da pesquisa, foram realizadas entrevistas individuais. Para tanto, usados: Questionário Sociodemográfico, Inventário de Sintomas de Stress para Adultos de Lipp (ISSL) e Inventário de Depressão de Beck (BDI). Resultados: A presença de sintomas de estresse e depressão na amostra foi de 32 e 34%, respectivamente. Dentre os pacientes com estresse, a fase mais encontrada foi a de resistência (73%); seguida pela de quase exaustão (14%); exaustão (9%); e alerta (5%). Encontrou-se o predomínio de sintomas psicológicos de estresse na amostra pesquisada (59%), sendo 41% de sintomas físicos da mesma patologia. O nível de depressão foi avaliado pelos escores de cada paciente no BDI, sendo que 39 pacientes não apresentaram sintomas de depressão; treze apresentaram sintomas leves; seis, sintomas moderados; e um apresentou sintomas graves. Conclusão: Não foi identificada alta prevalência de estresse e depressão na amostra.Palavras-chave: Estresse; Depressão; Hemodiálise; Doença renal crônicaABSTRACTIntroduction: The patient undergoing hemodialysis may have an ambiguous feeling between the fear of living or dying. The chronic condition of renal disease and hemodialysis treatment are considered permanent stress sources. In addition to being more vulnerable to stress, they experience individual conditions which constitute losses that affect themselves and their families, and may present, as a result, depressive symptoms. Aims: To ascertain the prevalence of stress and depression in patients undergoing dialysis treatment at the School Hospital of Itajubá, in the state of Minas Gerais, Brazil. Methods: The survey was conducted individually, with 59 patients undergoing dialysis treatment at the School Hospital. After clarifying the research, individual interviews were conducted. Therefore, the Socio-Demographic questionnaires, the Inventory of Stress Symptoms for Adults Lipp (ISSL) and the Beck Depression Inventory (BDI), were the tools used in the interviews. Results: The presence of symptoms of stress and depression in the sample was 32 and 34% respectively. Among patients showing stress the biggest phase was resistance (73%), followed by near exhaustion (14%), exhaustion (9%) and alert (5%). It was found, in the studied sample, a predominance of psychological symptoms of stress 59%, and 41% of physical symptoms of the same pathology. The level of depression was assessed by the scores of each patient in the BDI questionnaire and 39 patients had no symptoms of depression; thirteen patients had mild symptoms, six moderate symptoms and one had severe symptoms. Conclusion: The results show that the prevalence of stress and depression in the sample was not ascertained as high prevalence.Keywords: Stress; Depression; Hemodialisys; Chronic renal disease


2021 ◽  
Author(s):  
Conor Wild ◽  
Loretta Norton ◽  
David Menon ◽  
David Ripsman ◽  
Richard Swartz ◽  
...  

Abstract As COVID-19 cases exceed hundreds of millions globally, it is clear that many survivors face cognitive challenges and prolonged symptoms. However, important questions about the cognitive impacts of COVID-19 remain unresolved. In the present online study, 485 volunteers who reported having had a confirmed COVID-positive test completed a comprehensive cognitive battery and an extensive questionnaire. This group performed significantly worse than pre-pandemic controls on cognitive measures of reasoning, verbal, and overall performance, and processing speed, but not short-term memory – suggesting domain-specific deficits. We identified two distinct factors underlying health measures: one varying with physical symptoms and illness severity, and one with mental health. Crucially, cognitive deficits were correlated with physical symptoms, but not mental health, and were evident even in cases that did not require hospitalisation. These findings suggest that the subjective experience of “long COVID” or “brain fog” relates to a combination of physical symptoms and cognitive deficits.


2020 ◽  
Vol 73 (2) ◽  
Author(s):  
Marina de Góes Salvetti ◽  
Caroline Silva Pereira Machado ◽  
Suzana Cristina Teixeira Donato ◽  
Adriana Marques da Silva

ABSTRACT Objectives: to analyze the prevalence of symptoms and their relationship with the quality of life of cancer patients. Methods: this is a cross-sectional study with 107 patients evaluated using a sociodemographic instrument, the hospital anxiety and depression scale (HADS) and the quality of life scale (EORTC-QLQ-C30). Pearson’s correlation test was used to evaluate the relationship between symptoms and quality of life. Results: prevalence of female patients (56.1%), 55 years as the mean age and 10 years of schooling. Fatigue (76.6%), insomnia (47.7%), pain (42.1%), loss of appetite (37.4%), anxiety (31.8%) and depression (21.5%) were identified. Anxiety and depression symptoms presented a negative correlation with quality of life and positive correlation with physical symptoms. Conclusions: fatigue, insomnia, pain and loss of appetite were the most common and most intense symptoms. Anxiety and depression symptoms presented a negative correlation with quality of life and positive correlation with physical symptoms.


2014 ◽  
Vol 9 (3) ◽  
pp. 222-228 ◽  
Author(s):  
Christine Anne Ganzer ◽  
Alan Roy Jacobs ◽  
Farin Iqbal

Finasteride is a synthetic 5-α reductase inhibitor, which prevents the conversion of testosterone to dihydrotestosterone and has been used for more than 20 years in the treatment of male pattern hair loss. Randomized, controlled trials have associated finasteride with both reversible and persistent adverse effects. In this pilot study, we sought to characterize sexual and nonsexual adverse effects that men reported experiencing at least 3 months after stopping the medication. Based on previous research on persistent side effects of finasteride, we constructed an Internet survey targeting six domains: physical symptoms, sexual libido, ejaculatory disorders, disorders of the penis and testes, cognitive symptoms, and psychological symptoms and was e-mailed to patients who reported experiencing symptoms of side effects of finasteride. Responses from 131 generally healthy men (mean age, 24 years) who had taken finasteride for male pattern hair loss was included in the analysis. The most notable finding was that adverse effects persisted in each of the domains, indicating the possible presence of a “post-finasteride syndrome.”


Sign in / Sign up

Export Citation Format

Share Document